Cancer Discovery
AACR's high-profile journal bridging discovery and the clinic: first-in-human targeted-therapy data, resistance mechanisms and translational biology.
Cancer Discovery has appeared monthly since 2011 and publishes early clinical results with deep correlative science (KRAS, menin, and other targeted agents' first reports), mechanisms of acquired resistance, and the AACR Cancer Progress Report coverage. Hybrid access; AACR annual meeting plenary papers frequently appear here.
Uses organoids and functional genomics to find what pancreatic cancers depend on beyond KRAS.
Built the pancreatic cancer organoid models now used to test drugs against a patient's own tumour.
A gastric cancer trialist who pioneered biomarker-driven umbrella trials in Korea and helped bring HER2 and Claudin 18.2 agents to Asian patients.
Radiation oncologist who showed a blood test can detect leftover lung cancer months before scans.
Nina Bhardwaj is a dendritic-cell immunologist running personalised neoantigen vaccine trials.
Worked out why BRAF inhibitors fail in colorectal cancer and how to combine drugs to overcome it.
Runs the NCT/DKTK MASTER programme that sequences whole genomes of rare and young-adult cancers to guide therapy.